Literature DB >> 19397940

Productivity of cyclohexanone oxidation of the recombinant Corynebacterium glutamicum expressing chnB of Acinetobacter calcoaceticus.

Eun-Hee Doo1, Won-Heong Lee, Hyo-Seel Seo, Jin-Ho Seo, Jin-Byung Park.   

Abstract

The biocatalytic efficiency of recombinant Corynebacterium glutamicum expressing the chnB gene encoding cyclohexanone monooxygenase (CHMO) of Acinetobacter calcoaceticus NCIMB 9871 was investigated. Optimization of an expression system and induction conditions enabled the recombinant biocatalyst to produce CHMO to a specific activity of ca. 0.5 U mg(-1) protein. Tight control of feeding of an energy source (i.e., glucose) and dissolved oxygen tension during fed-batch culture-based biotransformation allowed the cells to produce epsilon-caprolactone to a concentration of 16.0 g l(-1). The specific and volumetric productivity for cyclohexanone oxidation were 0.12 g g drycells(-1)h(-1) (17.5 U g(-1) of dry cells) and 2.3 g l(-1)h(-1) (330 U l(-1)), respectively. These values correspond to over 5.4- and 2.7-fold of recombinant Escherichia coli expressing the same gene under similar reaction conditions. It could be concluded that the recombinant C. glutamicum is a promising biocatalyst for Baeyer-Villiger oxidations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397940     DOI: 10.1016/j.jbiotec.2009.04.008

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  2 in total

1.  A New Strategy for Production of 5-Aminolevulinic Acid in Recombinant Corynebacterium glutamicum with High Yield.

Authors:  Peng Yang; Wenjing Liu; Xuelian Cheng; Jing Wang; Qian Wang; Qingsheng Qi
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

2.  Reductive whole-cell biotransformation with Corynebacterium glutamicum: improvement of NADPH generation from glucose by a cyclized pentose phosphate pathway using pfkA and gapA deletion mutants.

Authors:  Solvej Siedler; Steffen N Lindner; Stephanie Bringer; Volker F Wendisch; Michael Bott
Journal:  Appl Microbiol Biotechnol       Date:  2012-08-01       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.